Second Sight Medical Products (NASDAQ:EYES) has found a market niche for itself in the healthcare space developing implantable visual prosthetics to treat sight-impaired people....
For Immediate ReleaseChicago, IL – April 4, 2019 - Stocks in this week’s article are VALE S.A. (NYSE:VALE) , Second Sight Medical Products Inc. (NASDAQ:EYES) ,...
Bargain hunting or looking for stocks with a low price-to-earnings (P/E) ratio is among the widely-used investing strategies. Investors believe that the lower the P/E, the higher...
Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, which is intended to provide useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury. The company was founded in 1998 and is headquartered in Sylmar, California.